Multiresistant Shigella infections in Bangladesh.
Bennish
M
M
Eusof
A
A
Kay
B
B
Wierzba
T
T
D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use*; D001459:Bangladesh; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D009268:Nalidixic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D010403:Penicillin Resistance; D012762:Shigella dysenteriae / Q000187:drug effects; D013420:Sulfamethoxazole / Q000494:pharmacology / Q000627:therapeutic use*; D014295:Trimethoprim / Q000494:pharmacology / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D009268:Nalidixic Acid; D000667:Ampicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole